Medical researchers are constantly working to find new treatments to extend the survival time and quality of life for people living with mesothelioma. So we are always on the watch for new research developments to share with mesothelioma patients and their families.

Recent findings published in The Journal of Thoracic and Cardiovascular Surgery discuss the potential benefit of a surgery known as “salvage chest wall resection.” This procedure may help some patients who have had surgery for pleural mesothelioma live longer after the disease recurs, according to medwireNews, an independent clinical news service.

Mesothelioma is an incurable cancer caused by exposure to asbestos. Pleural mesothelioma is the form of the disease in which tumors grow in the lining of the lungs.

The study looked at 1,142 patients who underwent extensive mesothelioma surgery (extrapleural pneumonectomy or pleurectomy/decortication). According to medwireNews, the study found that in “47 patients who underwent chest wall resection for recurrence a median of 16.1 months after initial cytoreductive surgery, the median overall survival was favorable, at 44.9 months.”

The study found that survival time was greatest in patients whose cancer took longer to recur and those with epithelial mesothelioma, a less aggressive form of the disease.

The study concluded that for some patients, the procedure may be a “safe and effective therapeutic option in the management of localized chest wall recurrence of malignant pleural mesothelioma.”